Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Following subcutaneous administration in clinical models: Both components demonstrate prolonged absorption with peak plasma concentrations occurring 24-72 hours post-injection GLP3 exhibits approximately 6-day half-life enabling once-weekly dosing Cagrilintide demonstrates 120-165 hour half-life (5-7 days) suitable for weekly administration Lipid conjugation of both peptides enables albumin binding and extended systemic circulation Distribution patterns show systemic exposure with concentration in metabolically active tissues The fatty diacid modifications on both peptides (C20 for GLP3 , eicosanedioic acid for cagrilintide) serve as albumin-binding moieties that dramatically extend plasma residence time compared to native peptides
The habits youve built now help keep the weight off for good, and our doctors and weight loss specialists continue to guide you every step of the way
This approach helps preserve muscle mass and reduces the risk of injury
Two reasons working simultaneously
US$ 29.33
US$ 28.98
US$ 22.87
US$ 26.27
US$ 21.41
US$ 28.78
